Cargando…
Antithymocyte-globulin/ciclosporin/eltrombopag: Lack of efficacy: case report
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8733750/ http://dx.doi.org/10.1007/s40278-022-08414-x |
Ejemplares similares
-
Antithymocyte-globulin/dexamethasone/remdesivir: COVID-19, lack of efficacy and off-label use: 2 case reports
Publicado: (2021) -
Ciclosporin/rituximab: Lack of efficacy and COVID-19: case report
Publicado: (2020) -
Antithymocyte-globulin/mycophenolate-mophetil: Lymphopenia: 3 case reports
Publicado: (2021) -
Antithymocyte globulin/methylprednisolone: COVID-19 infection: case report
Publicado: (2021) -
Reactivation of Hemophagocytic Lymphohistiocytosis Triggered by Antithymocyte Globulin
por: Matsuda, Kensuke, et al.
Publicado: (2017)